Frequency of monoclonal gammopathy in psoriatic patients receiving anti-TNF therapy compared with patients taking conventional drugs: a cross-sectional study

J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2262-3. doi: 10.1111/jdv.12565. Epub 2014 Jun 9.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Acitretin / therapeutic use
  • Adalimumab / therapeutic use
  • Adult
  • Age Factors
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Cross-Sectional Studies
  • Cyclosporine / therapeutic use
  • Etanercept / therapeutic use
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infliximab / therapeutic use
  • Keratolytic Agents / therapeutic use
  • Male
  • Methotrexate / therapeutic use
  • Middle Aged
  • Monoclonal Gammopathy of Undetermined Significance / epidemiology*
  • Prevalence
  • Psoriasis / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunosuppressive Agents
  • Keratolytic Agents
  • Tumor Necrosis Factor-alpha
  • Cyclosporine
  • Infliximab
  • Adalimumab
  • Acitretin
  • Etanercept
  • Methotrexate